Publication
Article
BioPharm International
BioPharm International-08-01-2002Volume15 Issue 8
Inside Washington: User Fee Program Seeks to Spur Biotech Development
Author(s):
PDUFA III boost manufacturer fees to cover postapproval surveillance and streamline the FDA review process
Articles in this issue
Guest Editorial: Quality Agreements with Contract Laboratories
Survival Guide to FDA Inspections: Part 1, To Prepare or Not to Prepare, There Is No Question
Virus Inactivation in the 1990s ? and into the 21st Century: Part 2, Red Blood Cells and Platelets
Making Regulatory Compliance a Core Process: Director and Officer Liability Exposure
Inside Washington: User Fee Program Seeks to Spur Biotech Development
Analytical Advances: Mapping Proteins – the 2-D Electrophoresis Issue
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Videos
Related Content
